Topics

Companies Related to "Novartis Novartis ofatumumab demonstrates superiority versus Aubagio head" [Most Relevant Company Matches] RSS

12:43 EST 13th November 2019 | BioPortfolio

Here are the most relevant search results for "Novartis Novartis ofatumumab demonstrates superiority versus Aubagio head" found in our extensive corporate database of over 50,000 company records.

Showing "Novartis Novartis ofatumumab demonstrates superiority versus Aubagio head" Companies 1–25 of 393

Extremely Relevant

Novartis Consumer Health

Novartis provides healthcare solutions that address the evolving needs of patients and societies. Focused solely on healthcare, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, cost-saving generic pharmaceuticals, preventive vaccines, diagnostic tools and consumer health products. Novartis is the only company with leading positions in each of these areas. In ...


Novartis Pharmaceuticals Corporation (NPC), a US subsidiary of Novartis AG

Novartis AG

Novartis's name, derived from the Latin novae artes, means "new skills" and reflects Novartis's commitment to focus research and development to bring new healthcare products to the patients and physicians. Headquartered in Basel, Switzerland, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, eye care, cost-saving generic pharmaceuticals, pr...


Novartis Vaccines and Diagnostics

Novartis Vaccines is a global leader in providing vaccines to protect against deadly meningococcal disease. Through industry-leading scientific expertise, the company is focused on extending critical meningococcal vaccines research. In addition to developing Menveo vaccine, Novartis Vaccines is developing a recombinant vaccine for its potential to provide broad coverage against multiple strains of...

Idenix Pharmaceuticals

Idenix is pursuing a disciplined business strategy that seeks to capitalize upon the diverse expertise of the company’s management team. While Idenix is focused on bringing its late-stage product candidates to market, it also believes that maintaining a full pipeline of drug candidates with the potential to become first- or best-in-class therapies for large and growing markets is critical to its...

Relevant

Venture Valuation Inc.

Venture Valuation was founded in spring 1999 based on research work by the founder and CEO, Patrik Frei, at the University of St. Gallen (HSG) and the Swiss Federal Institute of Technology in Lausanne (EPFL). Since the very beginning, Novartis Venture Fund (part of the worldwide life science company Novartis International AG) is a main customer for which Venture Valuation carries out all external ...

MyoPowers Medical Technologies SA

MyoPowers Medical Technologies, formerly known as Nanopowers, was founded by Dr Piergiorgio Tozzi of the University Hospital of Lausanne (CHUV) and Professor Daniel Hayoz of the Cantonal Hospital of Fribourg and the CHUV. In 2009, the company was selected as one of the best innovative medical technology companies by the Swiss Commission for Technology and ...

Novartis Oncology

AICOS Technologies AG

After the announcement in March 1996 by the two large pharmaceutical companies, Ciba-Geigy AG and Sandoz AG, of their intention to merge and form a new company, Novartis, it soon became clear that parts of this company would be "outsourced". The so-called Novartis Venture Fund was created to help the creation of small high-tech companies in the process of the merger. AICOS Technologies AG is one o...

Genomics Institute of the Novartis Research Foundation

The Genomics Institute of the Novartis Research Foundation (GNF) has integrated state of the art technologies, making possible new approaches to complex biomedical problems in the neurosciences, immunology and cancer biology. These technologies cut across the life sciences and include genomics and proteomics tools, combinatorial chemistry, structural genomics and computational biology. The mission...

Cadent Therapeutics

Cadent Therapeutics is creating breakthrough therapies for the treatment of movement disorders and cognitive impairment. The company combines target specificity, patient selection, drug design and optimization, and novel quantitative endpoints to create first-in-class molecules to treat movement and cognitive disorders. Cadent Therapeutics is rapidly advan...

Syngenta

Syngenta is a new company, with a proud history.Syngenta was formed in late 2000, bringing together the strengths of Novartis Agribusiness and Zeneca Agrochemicals to create a new global company with an exclusive focus on agribusiness.

Sandoz International GmbH

Sandoz, a Novartis company, is a world leader in generic pharmaceuticals. The company develops, manufactures and markets these medicines as well as pharmaceutical and biotechnological active ingredients.In 2005, Sandoz acquired Hexal, one of Germany’s leading generics company, and Eon Labs, one of the fastest-growing generic pharmaceuticals companies in the US. These acquisitions significantly s...

Neovacs S.A.

Neovacs is a French biotechnology company focused on active immunotherapy for autoimmune and inflammatory diseases and cancer. Neovacs is a spin-off from Université Pierre et Marie Curie in Paris, founded in 1993 by the French immunologist Daniel Zagury, MD-PHD. Neovacs is a French biotechnology company focused on active immunotherapy for autoimmune and inflammatory diseases. Using its ...

Idera Pharmaceuticals

We are a biotechnology company engaged in the discovery and development of novel therapeutics that modulate immune responses through Toll-like receptors (TLR) for the treatment of multiple diseases.Idera Pharmaceuticals’ business strategy is to advance its clinical-stage cancer programs and to develop other applications of its technology through new partnerships. We currently are collaborating w...

Intrasphere

Intrasphere is headquartered in New York City. Our US office provides comprehensive consulting services including strategy, application development, systems integration & customization, validation compliance and production support to companies such as Pfizer, Merck, Eli Lilly and Novartis among others. By taking the time to understand your business, people, culture and objectives, we deliver supe...

RMi

RMi, headquartered in Des Moines, Iowa and with offices in New York City and Thousand Oaks, Calif., is a multi-channel marketing consultancy focused on the pharmaceutical and biotechnology industries. Since 2006, it has worked in more than 30 therapeutic classes, including anti-infectives, allergy, cardiovascular, oncology, infused products and vaccines. A...

Surface Oncology, Inc.

Surface is creating the next generation of immunotherapies for cancer. To fully unlock the potential of cancer immunotherapy, Surface is targeting a broader set of immune processes by which cancer cells evade immune recognition and attack. Our programs are built upon emerging, proprietary insights about how to improve the immune system’s recognition a...

Opentrons

Opentrons is making automation accessible for any lab, starting with affordable pipetting robots for biologists. With its easy-to-use hardware and an open software platform, Opentrons automates manual lab work and empowers collaborative research for life scientists. Opentrons has helped over 1,000 labs in 45 countries save time, money and lab costs -- including 47 of the top 50 academic universit...

The Head Case Company

Head Case is a family-owned, dad-driven, grassroots organization that is in agreement with concerned parents everywhere who simply want sports to be safer for their children. Head Case has one goal--to help protect young athletes from the risks of undetected cumulative concussions.

Euro RSCG Life

Euro RSCG Life aligns the company's 60 health-focused agencies into a network with more than 2,000 employees, offering advertising, public relations, event promotion, medical education, digital marketing, direct-to-patient and consulting services. Its client roster includes Biogen Idec, Novartis, Pfizer, sanofi-aventis, Shire, EMD Serono, Bristol-Myers Squibb and Merck. For more information, visit...

EquipNet

EquipNet is a leading provider of proactive asset management solutions and services to leading corporations in the biotech, pharmaceutical, chemical, food, beverage, and personal care industries, such as Novartis, Johnson and Johnson, Sanofi Aventis, Merck and many others. EquipNet’s vision is to revolutionize the way companies manage their surplus as...

NCS Technologies

"Innovating." "Solutions."These two words have described NCS Technologies throughout our over two decades of experience.Solving problems in corporate systems environments. Creating solutions for business challenges through hundreds of successful projects. Innovating the effective use of technology for some of the world’s leading businesses.AT&T. Aventis. AT&T Wireless. Bayer. Bristol-Myers ...

Centerview Partners

Alan Hartman joins Centerview Partners from Merrill Lynch where he has been in the mergers and acquisitions group for the past 15 years, most recently as Head of Americas M&A and Global Head of Healthcare M&A. Following the acquisition by Bank of America, he was appointed Head of Americas M&A for the combined organization.

EyeSense AG

EyeSense(TM) AG is a venture-backed diagnostic device company based in Basel, Switzerland, and with operations near Frankfurt am Main, Germany. EyeSense was founded in 2006 as a spinout from Ciba Vision AG (a Novartis company), and develops ophthalmic diagnostic systems focusing on glucose testing for diabetic patients. In addition to glucose, the testing platform being developed by EyeSense h...


More From BioPortfolio on "Novartis Novartis ofatumumab demonstrates superiority versus Aubagio head"

Quick Search

Corporate Database Quicklinks